Clinical trial NCT02414477 - References

Tobacco Toxicant Exposure — Metabolism of Deuterated NNN in Smokeless Tobacco Users

Citation(s)

•   American Nonsmokers' Rights Foundation
  (2013) Percent of Population Covered by 100% Smokefree Restaurant AND Bar Laws. http://no-smoke.org/pdf/RBpercentMap. pdf .
•   Beranek DT, Weis CC, Swenson DH
  A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography. Carcinogenesis. 1980 Jul;1(7):595-606. doi: 10.1093/carcin/1.7.595.
•   Boyle, P
  and Levin, P. (2008) World Cancer Report, 2008. IARC, Lyon, FR.
•   Burns DM, Dybing E, Gray N, Hecht S, Anderson C, Sanner T, O'Connor R, Djordjevic M, Dresler C, Hainaut P, Jarvis M, Opperhuizen A, Straif K
  Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control. 2008 Apr;17(2):132-41. doi: 10.1136/tc.2007.024158. No abstract available.
•   Carmella SG, Akerkar S, Hecht SS
  Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res. 1993 Feb 15;53(4):721-4.
•   Centers for Disease Control and Prevention (CDC)
  Current cigarette smoking among adults - United States, 2011. MMWR Morb Mortal Wkly Rep. 2012 Nov 9;61(44):889-94.
•   Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US)
  How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. Available from http://www.ncbi.nlm.nih.gov/books/NBK53017/
•   Ding, L
  , Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., Fulton, L., Fulton, R. S., Zhang, Q., Wendl, M. C., Lawrence, M. S., Larson, D. E., Chen, K., Dooling, D. J., Sabo, A., Hawes, A. C., Shen, H., Jhangiani, S. N., Lewis, L. R., Hall, O., Zhu, Y., Mathew, T., Ren, Y., Yao, J., Scherer, S. E., Clerc, K., Metcalf, G. A., Ng, B., Milosavljevic, A., Gonzalez-Garay, M. L., Osborne, J. R., Meyer, R., Shi, X., Tang, Y., Koboldt, D. C., Lin, L., Abbott, R., Miner, T. L., Pohl, C., Fewell, G., Haipek, C., Schmidt, H., Dunford-Shore, B. H., Kraja, A., Crosby, S. D., Sawyer, C. S., Vickery, T., Sander, S., Robinson, J., Winckler, W., Baldwin, J., Chirieac, L. R., Dutt, A., Fennell, T., Hanna, M., Johnson, B. E., Onofrio, R. C., Thomas, R. K., Tonon, G., Weir, B. A., Zhao, X., Ziaugra, L., Zody, M. C., Giordano, T., Orringer, M. B., Roth, J. A., Spitz, M. R., Wistuba, I. I., Ozenberger, B., Good, P. J., Chang, A. C., Beer, D. G., Watson, M. A., Ladanyi, M., Broderick, S., Yoshizawa, A., Travis, W. D., Pao, W., Province, M. A., Weinstock, G. M., Varmus, H. E., Gabriel, S. B., Lander, E. S., Gibbs, R. A., Meyerson, M., and Wilson, R. K. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075.
•   Fiore, M
  C., Jaén, C.R., and Baker, T.B. (2008) Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. U.S. Department of Health and Human Services. Public Health Service., Rockville, MD.
•   Fontham ET, Thun MJ, Ward E, Portier KM, Balch AJ, Delancey JO, Samet JM; ACS Cancer and the Environment Subcommittee
  American Cancer Society perspectives on environmental factors and cancer. CA Cancer J Clin. 2009 Nov-Dec;59(6):343-51. doi: 10.3322/caac.20041. Epub 2009 Oct 28. Erratum In: CA Cancer J Clin. 2010 Jan-Feb;60(1):62. Portier, Kenneth M [added].
•   Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, Maher CA, Fulton R, Fulton L, Wallis J, Chen K, Walker J, McDonald S, Bose R, Ornitz D, Xiong D, You M, Dooling DJ, Watson M, Mardis ER, Wilson RK
  Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell. 2012 Sep 14;150(6):1121-34. doi: 10.1016/j.cell.2012.08.024.
•   Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR
  Patterns of somatic mutation in human cancer genomes. Nature. 2007 Mar 8;446(7132):153-8. doi: 10.1038/nature05610.
•   Haglund J, Henderson AP, Golding BT, Tornqvist M
  Evidence for phosphate adducts in DNA from mice treated with 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Chem Res Toxicol. 2002 Jun;15(6):773-9. doi: 10.1021/tx015542o.
•   Haglund J, Rafiq A, Ehrenberg L, Golding BT, Tornqvist M
  Transalkylation of phosphotriesters using Cob(I)alamin: toward specific determination of DNA-phosphate adducts. Chem Res Toxicol. 2000 Apr;13(4):253-6. doi: 10.1021/tx990135m.
•   Haglund J, Van Dongen W, Lemiere F, Esmans EL
  Analysis of DNA-phosphate adducts in vitro using miniaturized LC-ESI-MS/MS and column switching: phosphotriesters and alkyl cobalamins. J Am Soc Mass Spectrom. 2004 Apr;15(4):593-606. doi: 10.1016/j.jasms.2003.12.012.
•   Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunnemann KD, Hoffmann D
  A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 1993 Nov 18;329(21):1543-6. doi: 10.1056/NEJM199311183292105.
•   Hecht SS, Chen CB, Hirota N, Ornaf RM, Tso TC, Hoffmann D
  Tobacco-specific nitrosamines: formation from nicotine in vitro and during tobacco curing and carcinogenicity in strain A mice. J Natl Cancer Inst. 1978 Apr;60(4):819-24. doi: 10.1093/jnci/60.4.819.
•   Hecht SS, Chen CB, Ornaf RM, Jacobs E, Adams JD, Hoffmann D
  Reaction of nicotine and sodium nitrite: formation of nitrosamines and fragmentation of the pyrrolidine ring. J Org Chem. 1978 Jan 6;43(1):72-6. doi: 10.1021/jo00395a017. No abstract available.
•   Hecht SS
  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998 Jun;11(6):559-603. doi: 10.1021/tx980005y. No abstract available.
•   Hecht SS
  Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003 Oct;3(10):733-44. doi: 10.1038/nrc1190. Erratum In: Nat Rev Cancer. 2004 Jan;4(1):84.
•   Hecht SS
  Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999 Jul 21;91(14):1194-210. doi: 10.1093/jnci/91.14.1194.
•   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
  Personal habits and indoor combustions. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1-538. No abstract available.
•   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
  Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2007;89:1-592. No abstract available.
•   Institute of Medicine (2012) Scientific Standards for Studies on Modified Risk Tobacco Products
  National Academy Press, Washington, D.C.
•   Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D
  Global cancer statistics. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4. Erratum In: CA Cancer J Clin. 2011 Mar-Apr;61(2):134.
•   Lao Y, Yu N, Kassie F, Villalta PW, Hecht SS
  Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N'-nitrosonornicotine. Chem Res Toxicol. 2007 Feb;20(2):246-56. doi: 10.1021/tx060208j.
•   Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, Yue P, Zhang Y, Pant KP, Bhatt D, Ha C, Johnson S, Kennemer MI, Mohan S, Nazarenko I, Watanabe C, Sparks AB, Shames DS, Gentleman R, de Sauvage FJ, Stern H, Pandita A, Ballinger DG, Drmanac R, Modrusan Z, Seshagiri S, Zhang Z
  The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature. 2010 May 27;465(7297):473-7. doi: 10.1038/nature09004.
•   National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD
  Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
•   Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P
  Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 2002 Oct 21;21(48):7435-51. doi: 10.1038/sj.onc.1205803.
•   Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordonez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ
  A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 2010 Jan 14;463(7278):184-90. doi: 10.1038/nature08629. Epub 2009 Dec 16.
•   Reynolds M, Peterson E, Quievryn G, Zhitkovich A
  Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J Biol Chem. 2004 Jul 16;279(29):30419-24. doi: 10.1074/jbc.M402486200. Epub 2004 Apr 15.
•   Shafey, O
  , Eriksen, M.P., Ross, H., and Mackay, J. (2009) The Tobacco Atlas, 3rd Edition. American Cancer Society and World Lung Foundation, Atlanta, GA.
•   Siegel R, Naishadham D, Jemal A
  Cancer statistics, 2013. CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
•   Singer, B
  and Grunberger, D. (1983) Molecular Biology of Mutagens and Carcinogens. Plenum Press, New York.
•   Surveillance Research Program, N
  C. I. (2013) Fast Stats: An interactive tool for access to SEER cancer statistics. http://seer.cancer.gov/faststats (Accessed on 5-21-2013).
•   U
  S.Department of Health and Human Services. (2013) National Toxicology Program. http://ntp.niehs.nih.gov/
•   U
  S.Food and Drug Administration (2012) Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List. Fed. Regist. 77, 20034-20037.
•   United States Department of Health and Human Services (2009) National Survey on Drug Use and Health
  Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Washington, D.C.
•   Vogel RI, Carmella SG, Stepanov I, Hatsukami DK, Hecht SS
  The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers. Biomarkers. 2011 Sep;16(6):491-7. doi: 10.3109/1354750X.2011.598565. Epub 2011 Aug 3.
•   Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW
  Cancer genome landscapes. Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
•   World Health Organization
  (2012) Cancer Fact Sheet No. 297, February 2012 (http://www.who.int/mediacentre/factsheets/fs297/en/index.html).
•   Yuan JM, Gao YT, Murphy SE, Carmella SG, Wang R, Zhong Y, Moy KA, Davis AB, Tao L, Chen M, Han S, Nelson HH, Yu MC, Hecht SS
  Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res. 2011 Nov 1;71(21):6749-57. doi: 10.1158/0008-5472.CAN-11-0209. Epub 2011 Oct 25.
•   Yuan JM, Knezevich AD, Wang R, Gao YT, Hecht SS, Stepanov I
  Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis. 2011 Sep;32(9):1366-71. doi: 10.1093/carcin/bgr125. Epub 2011 Jul 6.
•   Zhang S, Wang M, Villalta PW, Lindgren BR, Lao Y, Hecht SS
  Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N'-nitrosonornicotine. Chem Res Toxicol. 2009 May;22(5):949-56. doi: 10.1021/tx900040j.
•   Zhang S, Wang M, Villalta PW, Lindgren BR, Upadhyaya P, Lao Y, Hecht SS
  Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem Res Toxicol. 2009 May;22(5):926-36. doi: 10.1021/tx900015d.

Metabolism of Deuterated NNN in Smokeless Tobacco Users

Details for clinical trial NCT02414477